Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology

Clinical trial NCT02158169 · COMPLETED

Trial details

NCT number: NCT02158169
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Chemotherapy-induced Anemia

Start date: 2012-06-01
Primary completion: 2014-12-01
Enrollment: 2167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.